Volume 29, Number 6—June 2023
CME ACTIVITY - Synopsis
Neurologic Complications of Babesiosis, United States, 2011–2021
Table 4
Comorbid condition |
Confusion/delirium, no. (%) |
Adjusted odds of confusion/delirium |
Impaired consciousness, no. (%) |
Adjusted odds of impaired consciousness |
||
---|---|---|---|---|---|---|
OR (95% CI) |
p value |
OR (95% CI) |
p value |
|||
Diabetes mellitus | ||||||
No | 140 (13.6) | 1.00 | 140 (10.7) | |||
Yes |
23 (34.8) |
3.04 (1.11–8.34) |
0.031 |
23 (39.1) |
5.36 (1.98–14.48) |
<0.001 |
Stroke/transient ischemic attack | ||||||
No | 150 (14.7) | |||||
Yes | 13 (38.5) | 3.06 (0.88–10.66) | 0.079 |
*Univariate logistic regression models tested associations between the following comorbid conditions and the 3 most frequent neurologic symptoms (headache, confusion/delirium, impaired consciousness): cardiac disorder, hypertension, diabetes mellitus, immunocompromised status, stroke/transient ischemic attack, obesity, chronic kidney disease, migraine, and malignancy. Variables that were significant in unadjusted univariate analysis were entered into a multivariate model for each neurologic symptom. The significance level for univariate and multivariate analysis was set to p<0.05. Boldface indicates statistical significance.
1These first authors contributed equally to this article.
2These senior authors contributed equally to this article.
Page created: April 13, 2023
Page updated: May 19, 2023
Page reviewed: May 19, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.